iMD Companies and Subsidiary Riize Health Unveil Strategic Expansion Into the Non-Prescription Medicine Supplement Market With New Product Launch Timeline
iMD Companies (OTC:ICBU) and its subsidiary Riize have announced plans to launch three new non-prescription supplements in Q1 2025. Following a 6x growth in sales order volume in their first year of telemedicine operations, Riize will expand into the over-the-counter market through RiizeUp.com.
The new products include Riize Energy for endurance and focus, Riize Sleep for relaxation, and Riize Xtra for sexual vitality. All products utilize their rapid-dissolving oral strip technology, offering 90% bioavailability compared to traditional supplements' 10-30%. The supplements target markets with projected CAGRs of 6-10% in coming years.
iMD Companies (OTC:ICBU) e la sua controllata Riize hanno annunciato piani per lanciare tre nuovi integratori da banco nel primo trimestre del 2025. Dopo una crescita di 6 volte nel volume degli ordini di vendita nel loro primo anno di operazioni di telemedicina, Riize si espanderà nel mercato dei prodotti da banco tramite RiizeUp.com.
I nuovi prodotti includono Riize Energy per resistenza e concentrazione, Riize Sleep per rilassamento, e Riize Xtra per vitalità sessuale. Tutti i prodotti utilizzano la loro tecnologia di strisce orali a rapido scioglimento, offrendo un biodisponibilità del 90% rispetto al 10-30% degli integratori tradizionali. Gli integratori mirano a mercati con tassi di crescita annuale composto (CAGR) previsti del 6-10% nei prossimi anni.
iMD Companies (OTC:ICBU) y su filial Riize han anunciado planes para lanzar tres nuevos suplementos sin receta en el primer trimestre de 2025. Tras un crecimiento de 6x en el volumen de pedidos en su primer año de operaciones de telemedicina, Riize se expandirá al mercado de venta libre a través de RiizeUp.com.
Los nuevos productos incluyen Riize Energy para resistencia y enfoque, Riize Sleep para relajación, y Riize Xtra para vitalidad sexual. Todos los productos utilizan su tecnología de tiras orales de rápida disolución, ofreciendo un 90% de biodisponibilidad en comparación con el 10-30% de los suplementos tradicionales. Los suplementos están dirigidos a mercados con tasas de crecimiento anual compuesto (CAGR) proyectadas del 6-10% en los próximos años.
iMD Companies (OTC:ICBU)와 그 자회사 Riize는 2025년 1분기에 새로운 비처방 보충제를 세 가지 출시할 계획이라고 발표했습니다. 원격 의료 운영의 첫 해에 판매 주문량이 6배 성장한 후, Riize는 RiizeUp.com을 통해 일반 시장으로 확장할 것입니다.
새로운 제품에는 지구력과 집중력을 위한 Riize Energy, 이완을 위한 Riize Sleep, 성적 활력을 위한 Riize Xtra가 포함됩니다. 모든 제품은 빠르게 용해되는 구강 스트립 기술을 활용하여 전통적인 보충제의 10-30%에 비해 90%의 생체이용률을 제공합니다. 이 보충제들은 향후 몇 년간 6-10%의 예상 연평균 성장률(CAGR)이 있는 시장을 대상으로 합니다.
iMD Companies (OTC:ICBU) et sa filiale Riize ont annoncé des projets de lancement de trois nouveaux suppléments en vente libre au premier trimestre 2025. Après une croissance de 6x du volume des commandes de vente au cours de leur première année d'opérations de télémédecine, Riize s'étendra sur le marché des produits en vente libre via RiizeUp.com.
Les nouveaux produits comprennent Riize Energy pour l'endurance et la concentration, Riize Sleep pour la relaxation, et Riize Xtra pour la vitalité sexuelle. Tous les produits utilisent leur technologie de bandes orales à dissolution rapide, offrant une biodisponibilité de 90% par rapport aux 10-30% des suppléments traditionnels. Les suppléments ciblent des marchés avec des taux de croissance annuel composé (CAGR) prévus de 6-10% dans les années à venir.
iMD Companies (OTC:ICBU) und ihre Tochtergesellschaft Riize haben Pläne angekündigt, im ersten Quartal 2025 drei neue rezeptfreie Ergänzungsmittel auf den Markt zu bringen. Nach einem Wachstum von 6x im Verkaufsbestellvolumen im ersten Jahr ihrer Telemedizin-Betrieb wird Riize über RiizeUp.com in den rezeptfreien Markt expandieren.
Die neuen Produkte umfassen Riize Energy für Ausdauer und Konzentration, Riize Sleep zur Entspannung und Riize Xtra für sexuelle Vitalität. Alle Produkte nutzen ihre technologie der schnell auflösenden oralen Streifen, die eine Bioverfügbarkeit von 90% im Vergleich zu den 10-30% traditioneller Ergänzungsmittel bieten. Die Ergänzungsmittel zielen auf Märkte mit prognostizierten jährlichen Wachstumsraten (CAGR) von 6-10% in den kommenden Jahren ab.
- 6x growth in sales order volume in first year of telemedicine operations
- Superior bioavailability (90%) compared to traditional supplements (10-30%)
- Expansion into high-growth supplement market (6-10% CAGR)
- Innovative delivery system with proprietary oral strip technology
- None.
RANCHO CORDOVA, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- iMD Companies, Inc. (OTC:ICBU) and its subsidiary, Riize LLC, are excited to announce the launch of three new products for online and retail distribution direct to the consumer supplement market in the first quarter of 2025.
Riize LLC (as RiizeHealth.com) has established itself as a leading innovator in telemedicine with online prescription medications for sexual health, weight control and hair loss, using oral dissolving film strip technology. Having experienced dynamic growth of 6x in sales order volume in the first year, that success will now be applied to the non-prescription, over-the-counter supplement market, on a newly dedicated platform - RiizeUp.com.
The new supplement products are designed for Energy, Sleep and Sexual Performance, which are the three strongest areas of supplement growth and demand. Projected compound annual growth rates (CAGRs) are from
The three products launching in Q1 2025 are:
- Riize Energy: Designed to boost energy, endurance, and mental focus.
- Riize Sleep: Promotes relaxation and restful, healthy sleep.
- Riize Xtra: Supports circulation and testosterone production for enhanced energy, stamina, and sexual vitality.
Each product is formulated with premium natural ingredients, including vitamins and herbs, and utilizes Riize’s signature rapid-dissolving oral strip technology. This delivery system offers superior bioavailability, ensuring that
Reilly Schueler, CEO of Riize LLC, commented, "Our success in the telemedicine space has shown us the potential for growth in consumer wellness products. With these new non-prescription medicine supplements, we are bringing the same cutting-edge oral strip technology to the market, offering consumers a fast, effective, and innovative supplement experience. We believe this expansion into the non-prescription medicine space will drive significant growth for Riize and strengthen our brand's leadership in health and wellness."
Rick Wilson, President and CEO of IMD Companies, Inc., added, "We are incredibly proud of what Riize LLC has achieved in such a short period. The combination of their innovative technology and consumer-focused products positions them perfectly for success in the rapidly growing non-prescription medicine market. This move represents a tremendous growth opportunity for both Riize and ICBU, and we look forward to seeing this new chapter unfold."
Follow Riize Social Media
Website @ https://www.riizehealth.com
Canada @ ca.riizehealth.com
Facebook @ https://www.facebook.com/riizehealth
Instagram @ https://www.instagram.com/riizehealth/
Tiktok @ https://www.tiktok.com/@riize_up_llc
Blogs @ https://riizehealth.com/pages/recent-blog-post
About Riize, LLC
Riize is revolutionizing the healthcare industry as a leading telemedicine/pharmacy services provider. Our specialized focus on men’s and women’s sexual health and weight loss sets us apart from the competition due to our revolutionary delivery system. We are proud to offer a convenient and innovative online healthcare service that connects individuals with licensed healthcare providers. At Riize, we understand the importance of personalized care. That’s why we provide a platform where patients can easily consult with healthcare professionals remotely. Through video or phone calls, individuals can discuss their symptoms, receive accurate diagnoses, and obtain personalized treatment plans that address their specific needs. We believe in breaking down barriers to healthcare access. With Riize, patients no longer have to endure long wait times or travel to a physical clinic. Our user-friendly platform ensures that quality healthcare is just a few clicks away. Join us in shaping the future of healthcare. Experience the convenience and expertise that Riize offers. Your health and well-being are our priorities.
Follow iMD Companies, Inc. Social Media
Twitter @ https://twitter.com/imd_inc
Instagram @ https://www.instagram.com/imdcompaniesinc/
About iMD Companies, Inc.
iMD Companies. Inc. (OTC:ICBU) is a Florida Corporation. The company has been re-positioned to be a holding company for acquisitions and technology development in the healthcare markets. iMD's goal is to combine the expertise of our team members to create a cohesive force, which will carry the company forward in the marketplace.
Safe Harbor Statement
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Contact:
iMD Companies, Inc.
info@imdcompaniesinc.com
FAQ
When will ICBU launch its new supplement products?
What are the three new supplements ICBU is launching through RiizeUp.com?
How much better is ICBU's oral strip technology compared to traditional supplements?
What growth has Riize achieved in its first year of operations?
What is the projected market growth rate for ICBU's new supplement categories?
